Literature DB >> 19461390

A 5-day dialectical behavior therapy partial hospital program for women with borderline personality disorder: predictors of outcome from a 3-month follow-up study.

Shirley Yen1, Jennifer Johnson, Ellen Costello, Elizabeth B Simpson.   

Abstract

OBJECTIVE: This study describes naturalistic 3-month follow-up after discharge from a 5-day partial hospitalization dialectical behavior therapy (DBT) program for women diagnosed with borderline personality disorder (BPD). We also examined individual BPD criteria as predictors of treatment response.
METHODS: Fifty women diagnosed with BPD were consecutively recruited from a partial hospital DBT program, 47 of whom (94%) completed all assessments including baseline (prior to discharge) and 3-months post-discharge assessments. Most continued with some combination of individual psychotherapy and pharmacotherapy, and all had the option of continuing with weekly DBT skills classes. Baseline scores were compared to 3-month scores using paired two-tailed non-parametric (sign) tests. Regression analyses were conducted to identify predictors of outcome.
RESULTS: Depression, hopelessness, anger expression, dissociation, and general psychopathology scores significantly decreased over the 3-month follow-up interval, although scores on several measures remained in the clinical range. Those who endorsed emptiness, impulsivity, and relationship disturbance demonstrated improvement on a number of outcomes, while those who endorsed identity disturbance and fear of abandonment had less improvement on some outcomes.
CONCLUSION: These findings illustrate (1) that improvement occurred over a 3-month interval on a number of measures in patients receiving treatment as usual following discharge from a partial hospitalization program, and (2) that BPD is a complex, heterogeneous disorder for which there is no single pathognomonic criterion, so that each criterion should be considered individually in determining its potential effect on treatment outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461390      PMCID: PMC2842988          DOI: 10.1097/01.pra.0000351877.45260.70

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  30 in total

1.  Internal consistency, intercriterion overlap and diagnostic efficiency of criteria sets for DSM-IV schizotypal, borderline, avoidant and obsessive-compulsive personality disorders.

Authors:  C M Grilo; T H McGlashan; L C Morey; J G Gunderson; A E Skodol; M T Shea; C A Sanislow; M C Zanarini; D Bender; J M Oldham; I Dyck; R L Stout
Journal:  Acta Psychiatr Scand       Date:  2001-10       Impact factor: 6.392

2.  Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association.

Authors: 
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

3.  Borderline personality disorder features predict negative outcomes 2 years later.

Authors:  Courtney Bagge; Angela Nickell; Stephanie Stepp; Christine Durrett; Kristina Jackson; Timothy J Trull
Journal:  J Abnorm Psychol       Date:  2004-05

4.  Borderline personality disorder criteria associated with prospectively observed suicidal behavior.

Authors:  Shirley Yen; M Tracie Shea; Charles A Sanislow; Carlos M Grilo; Andrew E Skodol; John G Gunderson; Thomas H McGlashan; Mary C Zanarini; Leslie C Morey
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

5.  A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial.

Authors:  Joan M Farrell; Ida A Shaw; Michael A Webber
Journal:  J Behav Ther Exp Psychiatry       Date:  2009-01-14

6.  Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up.

Authors:  A Bateman; P Fonagy
Journal:  Am J Psychiatry       Date:  2001-01       Impact factor: 18.112

7.  Short-term diagnostic stability of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders.

Authors:  M Tracie Shea; Robert Stout; John Gunderson; Leslie C Morey; Carlos M Grilo; Thomas McGlashan; Andrew E Skodol; Regina Dolan-Sewell; Ingrid Dyck; Mary C Zanarini; Martin B Keller
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

Review 8.  Chronic suicidality among patients with borderline personality disorder.

Authors:  Joel Paris
Journal:  Psychiatr Serv       Date:  2002-06       Impact factor: 3.084

9.  An investigation of the prototype validity of the borderline DSM-IV construct.

Authors:  M Johansen; S Karterud; G Pedersen; T Gude; E Falkum
Journal:  Acta Psychiatr Scand       Date:  2004-04       Impact factor: 6.392

10.  Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial.

Authors:  Martin Bohus; Brigitte Haaf; Timothy Simms; Matthias F Limberger; Christian Schmahl; Christine Unckel; Klaus Lieb; Marsha M Linehan
Journal:  Behav Res Ther       Date:  2004-05
View more
  10 in total

1.  Measuring the shadows: A systematic review of chronic emptiness in borderline personality disorder.

Authors:  Caitlin E Miller; Michelle L Townsend; Nicholas J S Day; Brin F S Grenyer
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

Review 2.  Psychotherapy for Borderline Personality Disorder: Progress and Remaining Challenges.

Authors:  Paul S Links; Ravi Shah; Rahel Eynan
Journal:  Curr Psychiatry Rep       Date:  2017-03       Impact factor: 5.285

Review 3.  Psychological therapies for people with borderline personality disorder.

Authors:  Jutta M Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

4.  Predictors of treatment response to an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder.

Authors:  Kim L Gratz; Katherine L Dixon-Gordon; Matthew T Tull
Journal:  Personal Disord       Date:  2014-01

5.  Both trait and state mindfulness predict lower aggressiveness via anger rumination: A multilevel mediation analysis.

Authors:  Tory A Eisenlohr-Moul; Jessica R Peters; Richard S Pond; C Nathan DeWall
Journal:  Mindfulness (N Y)       Date:  2016-03-09

6.  Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study.

Authors:  Fernando Lana; Carmen Sánchez-Gil; Núria D Adroher; Víctor Pérez; Guillem Feixas; Josep Martí-Bonany; Marta Torrens
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-21       Impact factor: 2.570

Review 7.  Current state of the evidence on community treatments for people with complex emotional needs: a scoping review.

Authors:  Sarah Ledden; Luke Sheridan Rains; Merle Schlief; Phoebe Barnett; Brian Chi Fung Ching; Brendan Hallam; Mia Maria Günak; Thomas Steare; Jennie Parker; Sarah Labovitch; Sian Oram; Steve Pilling; Sonia Johnson
Journal:  BMC Psychiatry       Date:  2022-09-05       Impact factor: 4.144

Review 8.  Chronic complex dissociative disorders and borderline personality disorder: disorders of emotion dysregulation?

Authors:  Bethany L Brand; Ruth A Lanius
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2014-10-14

9.  Efficacy and cost-effectiveness of an experimental short-term inpatient Dialectical Behavior Therapy (DBT) program: study protocol for a randomized controlled trial.

Authors:  Louisa M C van den Bosch; Roland Sinnaeve; Leona Hakkaart-van Roijen; Eric F van Furth
Journal:  Trials       Date:  2014-05-01       Impact factor: 2.279

10.  The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol.

Authors:  Shelley F McMain; Alexander L Chapman; Janice R Kuo; Tim Guimond; David L Streiner; Katherine L Dixon-Gordon; Wanrudee Isaranuwatchai; Jeffrey S Hoch
Journal:  BMC Psychiatry       Date:  2018-07-17       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.